Mariner’s Sage Therapeutics SAGE Stock Holding History

Mariner’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34,150	Closed	-$311K	–	3733
2025 Q2	$311K	Buy	34,150 +14,144	+71%	+$104K	﹤0.01%	2702
2025 Q1	$159K	Buy	+20,006	New	+$146K	﹤0.01%	3074
2019 Q3	–	Sell	-2,077	Closed	-$380K	–	979
2019 Q2	$380K	Sell	2,077 -26	-1%	-$4.44K	﹤0.01%	800
2019 Q1	$334K	Buy	+2,103	New	+$305K	﹤0.01%	782

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's SAGE Position: Q3 2025 in Review

Mariner sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 34,150 shares — an estimated $311K sold.

Mariner first reported a position in SAGE in Q1 2019 and held it in 4 quarters. The position peaked at $380K in Q2 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Mariner reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Mariner sold 34,150 Sage Therapeutics shares in Q3 2025, an estimated $311K.
Mariner first reported a position in Sage Therapeutics in Q1 2019 and held it in 4 quarters.
Mariner's Sage Therapeutics position peaked at $380K in Q2 2019.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.